UnitedHealth Group (NYSE:UNH) Updates FY 2019 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided earnings per share guidance of $14.70-14.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $14.70. UnitedHealth Group also updated its FY19 guidance to $14.70-14.90 EPS.

NYSE UNH opened at $256.65 on Friday. The company has a quick ratio of 0.73, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $247.66 billion, a PE ratio of 18.59, a PEG ratio of 1.39 and a beta of 0.61. UnitedHealth Group has a 1 year low of $208.07 and a 1 year high of $287.94. The business has a 50-day simple moving average of $249.00.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.46 by $0.14. The business had revenue of $60.60 billion for the quarter, compared to analysts’ expectations of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The business’s revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the firm posted $3.14 EPS. As a group, equities analysts anticipate that UnitedHealth Group will post 14.71 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were given a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.68%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $0.90. The ex-dividend date of this dividend was Friday, June 14th. UnitedHealth Group’s payout ratio is presently 33.54%.

Several research firms have weighed in on UNH. Barclays set a $24.00 price objective on Tenet Healthcare and gave the company a hold rating in a research report on Wednesday, April 17th. Bank of America reaffirmed a buy rating and set a C$10.00 price objective on shares of Hexo in a research report on Wednesday, April 17th. Zacks Investment Research raised Golub Capital BDC from a hold rating to a buy rating and set a $20.00 price objective on the stock in a research report on Tuesday. UBS Group set a $36.00 price objective on Halliburton and gave the company a buy rating in a research report on Tuesday, April 23rd. Finally, Citigroup reaffirmed a buy rating on shares of Healthequity in a research report on Friday, May 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seventeen have issued a buy rating to the company’s stock. The company currently has an average rating of Buy and a consensus price target of $296.56.

In related news, CEO David S. Wichmann purchased 20,000 shares of the company’s stock in a transaction dated Friday, May 3rd. The shares were purchased at an average cost of $231.79 per share, with a total value of $4,635,800.00. Following the transaction, the chief executive officer now directly owns 904,367 shares in the company, valued at approximately $209,623,226.93. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total value of $2,480,000.00. Following the completion of the sale, the director now directly owns 187,663 shares in the company, valued at $46,540,424. The disclosure for this sale can be found here. Over the last three months, insiders sold 35,000 shares of company stock worth $8,392,500. Insiders own 0.87% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Investing in Growth Stocks

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.